日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes

在住院的2型糖尿病患者中,使用胰岛素甘精U300进行GlucoTab指导的胰岛素治疗能够有效控制血糖,并降低低血糖风险。

Aberer, Felix; Lichtenegger, Katharina M; Smajic, Edin; Donsa, Klaus; Malle, Oliver; Samonigg, Judith; Höll, Bernhard; Beck, Peter; Pieber, Thomas R; Plank, Johannes; Mader, Julia K

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients

TP53突变状态与III期结肠癌患者辅助5-氟尿嘧啶治疗获益的预测

Kandioler, Daniela; Mittlböck, Martina; Kappel, Sonja; Puhalla, Harald; Herbst, Friedrich; Langner, Cord; Wolf, Brigitte; Tschmelitsch, Jörg; Schippinger, Walter; Steger, Günther; Hofbauer, Friedrich; Samonigg, Hellmut; Gnant, Michael; Teleky, Bela; Kührer, Irene

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

基因组表达检测EndoPredict是一种预后工具,用于识别参与前瞻性ABCSG 8试验的绝经后内分泌受体阳性、HER2阴性乳腺癌患者的局部复发风险。

Fitzal, F; Filipits, M; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Dubsky, P; Bartsch, R; Kronenwett, R; Gnant, M

A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options

一种经糖基化改造的抗HER2单克隆抗体(TrasGEX)可使HER2过表达的转移性结直肠癌患者在所有可用治疗方案均失败后获得长期缓解。

Eisner, Florian; Pichler, Martin; Goletz, Steffen; Stoeger, Herbert; Samonigg, Hellmut

An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients

一项经内部和外部验证的转移性乳腺癌预后评分:对 2269 例患者的分析

Regierer, A C; Wolters, R; Ufen, M-P; Weigel, A; Novopashenny, I; Köhne, C H; Samonigg, H; Eucker, J; Possinger, K; Wischnewsky, M B

Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients

治疗前贫血是软组织肉瘤患者预后不良的因素。

Szkandera, Joanna; Gerger, Armin; Liegl-Atzwanger, Bernadette; Stotz, Michael; Samonigg, Hellmut; Ploner, Ferdinand; Stojakovic, Tatjana; Leithner, Andreas; Pichler, Martin

Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients

在一项大型胰腺癌患者队列研究中,评估尿酸作为预后血液标志物的价值

Stotz, Michael; Szkandera, Joanna; Seidel, Julia; Stojakovic, Tatjana; Samonigg, Hellmut; Reitz, Daniel; Gary, Thomas; Kornprat, Peter; Schaberl-Moser, Renate; Hoefler, Gerald; Gerger, Armin; Pichler, Martin

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

通过全基因组测序鉴定前列腺癌患者循环系统中与肿瘤相关的拷贝数变化

Heitzer, Ellen; Ulz, Peter; Belic, Jelena; Gutschi, Stefan; Quehenberger, Franz; Fischereder, Katja; Benezeder, Theresa; Auer, Martina; Pischler, Carina; Mannweiler, Sebastian; Pichler, Martin; Eisner, Florian; Haeusler, Martin; Riethdorf, Sabine; Pantel, Klaus; Samonigg, Hellmut; Hoefler, Gerald; Augustin, Herbert; Geigl, Jochen B; Speicher, Michael R

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

体重指数对绝经后乳腺癌患者接受阿那曲唑延长辅助内分泌治疗疗效的预测影响:一项基于随机ABCSG-6a试验的分析

Gnant, M; Pfeiler, G; Stöger, H; Mlineritsch, B; Fitzal, F; Balic, M; Kwasny, W; Seifert, M; Stierer, M; Dubsky, P; Greil, R; Steger, G; Samonigg, H; Fesl, C; Jakesz, R

Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer

利用癌症患者血浆DNA建立肿瘤特异性拷贝数变异

Heitzer, Ellen; Auer, Martina; Hoffmann, Eva Maria; Pichler, Martin; Gasch, Christin; Ulz, Peter; Lax, Sigurd; Waldispuehl-Geigl, Julie; Mauermann, Oliver; Mohan, Sumitra; Pristauz, Gunda; Lackner, Carolin; Höfler, Gerald; Eisner, Florian; Petru, Edgar; Sill, Heinz; Samonigg, Hellmut; Pantel, Klaus; Riethdorf, Sabine; Bauernhofer, Thomas; Geigl, Jochen B; Speicher, Michael R